Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ASM CVE:ITR NYSEARCA:SIL NASDAQ:SLS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASMAvino Silver & Gold Mines$6.53$6.73$2.98▼$11.99$1.10B1.685.97 million shs3.02 million shsITRIntegra ResourcesC$3.46+3.6%C$3.89C$1.93▼C$6.60C$699.79M2.017156403,606 shs92,806 shsSILGlobal X Silver Miners ETF$88.11$92.18$41.86▼$119.24$5.27B0.783.17 million shs769,797 shsSLSSELLAS Life Sciences Group$7.78$5.33$1.39▼$9.10$1.45B2.248.68 million shs10.65 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASMAvino Silver & Gold Mines0.00%-8.54%-5.50%-25.88%+113.40%ITRIntegra Resources0.00%-5.65%-18.54%-39.60%+46.49%SILGlobal X Silver Miners ETF0.00%-3.81%-7.13%-20.02%+106.54%SLSSELLAS Life Sciences Group0.00%+9.89%+74.44%+72.89%+311.64%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASMAvino Silver & Gold Mines$6.53$6.73$2.98▼$11.99$1.10B1.685.97 million shs3.02 million shsITRIntegra ResourcesC$3.46+3.6%C$3.89C$1.93▼C$6.60C$699.79M2.017156403,606 shs92,806 shsSILGlobal X Silver Miners ETF$88.11$92.18$41.86▼$119.24$5.27B0.783.17 million shs769,797 shsSLSSELLAS Life Sciences Group$7.78$5.33$1.39▼$9.10$1.45B2.248.68 million shs10.65 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASMAvino Silver & Gold Mines0.00%-8.54%-5.50%-25.88%+113.40%ITRIntegra Resources0.00%-5.65%-18.54%-39.60%+46.49%SILGlobal X Silver Miners ETF0.00%-3.81%-7.13%-20.02%+106.54%SLSSELLAS Life Sciences Group0.00%+9.89%+74.44%+72.89%+311.64%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASMAvino Silver & Gold Mines 2.50Moderate Buy$9.9251.86% UpsideITRIntegra Resources 3.25BuyC$8.75152.89% UpsideSILGlobal X Silver Miners ETF 2.75Moderate Buy$88.11N/ASLSSELLAS Life Sciences Group 2.00Hold$10.0028.53% UpsideCurrent Analyst Ratings BreakdownLatest ITR, SLS, ASM, and SIL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2026ASMAvino Silver & Gold Mines Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$8.005/14/2026ASMAvino Silver & Gold Mines HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$13.004/21/2026SLSSELLAS Life Sciences Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/17/2026ASMAvino Silver & Gold Mines HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.503/12/2026SLSSELLAS Life Sciences Group Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$7.00 ➝ $10.00(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASMAvino Silver & Gold Mines$112.82M9.76$0.28 per share23.19$0.83 per share7.87ITRIntegra ResourcesC$248.63M2.81C$1.01 per share3.41C$1.33 per share2.60SILGlobal X Silver Miners ETFN/AN/AN/AN/AN/AN/ASLSSELLAS Life Sciences GroupN/AN/AN/AN/A$0.58 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASMAvino Silver & Gold Mines$540K$0.22326.6693.29N/A6.57%12.13%10.16%N/AITRIntegra Resources-C$40.04MC$0.0486.50N/AN/A3.68%5.06%-17.95%N/ASILGlobal X Silver Miners ETFN/AN/A32.07N/AN/AN/AN/AN/AN/ASLSSELLAS Life Sciences Group-$26.86M-$0.23N/AN/AN/AN/A-47.12%-42.63%8/11/2026 (Estimated)Latest ITR, SLS, ASM, and SIL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026SLSSELLAS Life Sciences Group-$0.06-$0.05+$0.01-$0.05N/AN/A3/19/2026Q4 2025SLSSELLAS Life Sciences Group-$0.0633-$0.05+$0.0133-$0.05N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthASMAvino Silver & Gold MinesN/AN/AN/AN/AN/AITRIntegra ResourcesN/AN/AN/AN/AN/ASILGlobal X Silver Miners ETF$0.981.11%N/AN/AN/ASLSSELLAS Life Sciences GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASMAvino Silver & Gold Mines0.012.361.43ITRIntegra Resources13.504.961.49SILGlobal X Silver Miners ETFN/AN/AN/ASLSSELLAS Life Sciences GroupN/A17.2217.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASMAvino Silver & Gold Mines3.11%ITRIntegra Resources20.43%SILGlobal X Silver Miners ETFN/ASLSSELLAS Life Sciences Group17.38%Insider OwnershipCompanyInsider OwnershipASMAvino Silver & Gold Mines4.30%ITRIntegra Resources17.78%SILGlobal X Silver Miners ETFN/ASLSSELLAS Life Sciences Group1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASMAvino Silver & Gold Mines34168.57 million134.51 millionNot OptionableITRIntegra Resources41202.25 millionN/ANot OptionableSILGlobal X Silver Miners ETFN/A59.83 millionN/ANot OptionableSLSSELLAS Life Sciences Group10186.03 million183.43 millionNot OptionableITR, SLS, ASM, and SIL HeadlinesRecent News About These CompaniesSellas Life Sciences: REGAL Delay May Be A Warning Sign, Not A Bullish SignalMay 22 at 1:08 PM | seekingalpha.comSLS stock jumps premarket: CEO says GPS AML data has ‘very good chance’ to beat earlier survival outcomesMay 20, 2026 | msn.comSELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?May 20, 2026 | benzinga.comSELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?May 20, 2026 | benzinga.comSLS stock rallies after hours as CEO teases leukemia study data any day nowMay 19, 2026 | msn.comSELLAS Life Sciences (SLS) Is Up 50.5% After Pivotal AML Trial Nears Readout And Adds Funding Flexibility – Has The Bull Case Changed?May 16, 2026 | uk.finance.yahoo.comSLS stock hits 4-year high: BlackRock stake boost fuels buzz around looming AML trial readoutMay 14, 2026 | msn.comSELLAS Life Sciences to Participate in Upcoming Investor ConferencesMay 14, 2026 | globenewswire.comSLS on track to clock best week in over 4 months: Retail divided between stock drop or multibagger status amid upcoming leukemia trial readoutMay 13, 2026 | msn.comSELLAS rises as Q1 update suggests lead program nears final analysisMay 13, 2026 | seekingalpha.comSELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline ProgressesMay 13, 2026 | benzinga.comSELLAS Life Sciences surges on earnings beat, trial updateMay 12, 2026 | investing.comSELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate UpdateMay 12, 2026 | globenewswire.comSLS stock heads for weekly win: Deutsche Bank’s stake boost draws attention ahead of Q1 earningsMay 8, 2026 | msn.comSELLAS Life Sciences Group (SLS) Expected to Announce Earnings on TuesdayMay 5, 2026 | marketbeat.comSLS stock kicks off week in green: CEO flags role in EU biotech policy talks that could impact drug approvalsMay 4, 2026 | msn.comSLS stock tests $5 again: Retail targets 'no' vote on 20M share dilution push before AML trial resultsMay 1, 2026 | msn.comSELLAS Life Sciences Group (SLS) price target increased by 15.38% to 10.20April 28, 2026 | msn.comSLS stock jumps overnight: CEO doubles down on ‘steadfast’ confidence in AML drug and pushes for 20M share plan approvalApril 27, 2026 | msn.comSELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up - Still a Buy?April 27, 2026 | marketbeat.comWhy SELLAS Life Sciences Group, Inc.’s (SLS) Stock Is Down 6.79%April 26, 2026 | aaii.comANew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTarget the Red-Hot Spin-Off and Merger Space With These ETFsBy Nathan Reiff | May 17, 2026Boarding Passes Now Being Issued for the Ultimate eVTOL ArbitrageBy Jeffrey Neal Johnson | May 6, 2026The Great SPR Arbitrage: An Oil Market Glitch Fuels Sector GainsBy Jeffrey Neal Johnson | May 14, 20263 Metals and Mining Stocks Riding the Commodity SupercycleBy Chris Markoch | May 11, 2026A Real Biggie Deal: Wendy's Serves Up a Juicy Buyout ArbitrageBy Jeffrey Neal Johnson | May 13, 2026ITR, SLS, ASM, and SIL Company DescriptionsAvino Silver & Gold Mines NYSE:ASM$6.53 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$6.54 +0.01 (+0.11%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Avino Silver & Gold Mines Ltd. engages in the mining and exploration activities. It focuses on silver reserves in the Durango region of North Central Mexico. It operates through the Silver, Gold, and Copper segments. The company was founded on May 15, 1968 and is headquartered in Vancouver, Canada.Integra Resources CVE:ITRC$3.46 +0.12 (+3.59%) As of 04:00 PM EasternIntegra Resources Corp., a precious metals exploration and development company, engages in the acquisition, exploration, and development of mineral properties in the Great Basin of the Western United States. The company explores for gold and silver deposits. It primarily focuses on developing DeLamar Project located in southwestern Idaho; and the Wildcat and Mountain View Projects located in western Nevada. It also holds a portfolio of early-stage exploration projects in Idaho, Nevada, and Arizona. The company was formerly known as Mag Copper Limited and changed its name to Integra Resources Corp. in August 2017. Integra Resources Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.Global X Silver Miners ETF NYSEARCA:SIL$88.11 0.00 (0.00%) As of 05/22/2026 04:10 PM EasternThe Global X Silver Miners ETF (SIL) is an exchange-traded fund that mostly invests in materials equity. The fund tracks a market-cap-weighted index of companies actively engaged in the silver mining industry. SIL was launched on Apr 19, 2010 and is managed by Global X.SELLAS Life Sciences Group NASDAQ:SLS$7.78 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$7.78 0.00 (0.00%) As of 05/22/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
